Ana María Fernández Rodríguez-rekin lankidetzan egindako argitalpenak (8)

2020

  1. Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper

    Transplantation, Vol. 104, Núm. 8 2S Suppl 2, pp. S1-S12

2013

  1. A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation

    American Journal of Transplantation, Vol. 13, Núm. 2, pp. 493-500

  2. High incidence of delayed graft function in HIV-infected kidney transplant recipients

    Transplant International, Vol. 26, Núm. 9, pp. 893-902

2011

  1. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients

    American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971

2010

  1. Long-term graft function changes in kidney transplant recipients

    NDT Plus, Vol. 3, Núm. SUPPLL. 2

2009

  1. Manejo del injerto renal fallido. Nefrectomía versus embolización

    Nefrologia, Vol. 29, Núm. SUPP.1, pp. 55-61

  2. Retrasplante

    Nefrologia, Vol. 29, Núm. SUPP.1, pp. 63-71

2007

  1. Use of the New Proliferation Signal Inhibitor Everolimus in Renal Transplant Patients in Spain: Preliminary Results of the EVERODATA Registry

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2157-2159